News | September 26, 2011

Hoag Breast Care Center First in California Offering 3-D Mammography

September 26, 2011 — Hoag Breast Care Center recently became the first breast care center in California and one of a handful in the United States offering 3-D digital breast tomosynthesis for breast cancer screenings. The technology promises to improve breast cancer detection, especially in young women and women with radiographically dense breast tissue.

Digital breast tomosynthesis (DBT) is a U.S. Food and Drug Administration (FDA)-approved 3-D imaging modality that can identify and characterize individual breast structures without the confusion of overlapping tissue. It is especially beneficial for women with dense breasts.

Dense breast tissue can obscure an underlying cancer, or conversely mimic a cancer when none exists. Approximately 15 to 20 percent of breast cancers cannot be detected using traditional 2-D mammography, especially in women with dense breast tissue.

"It's a major milestone to be the first breast center in California to provide patients with digital breast tomosynthesis," said Gary M. Levine, M.D., director of breast imaging at Hoag Breast Care Center. "At Hoag we have been involved with the development and testing of tomosynthesis since 2009. Recent reader studies have confirmed digital breast tomosynthesis to be superior to conventional mammography alone at finding early breast cancer. Tomosynthesis will allow us to discover more early stage breast cancers, and early detection translates to lives saved."

During a tomosynthesis exam, 15 digital "projection" images are captured as the system arcs over the breast during a short four-second scan. These images are then digitally reconstructed into a series of high-resolution one-millimeter slices that can be reviewed individually or played back in a cine loop.

"Tomosynthesis, by solving the issue of tissue superimposition, will not only allow us to detect breast cancer more reliably, it will also reduce the number of unnecessary call backs for additional testing," Levine said. "This will then address a frequent criticism of mammography by reducing anxiety and controlling costs."

A woman can learn if her breasts are dense by asking her physician or the radiologist who performs her mammogram. Breast density is not based on family history and cannot be determined by look and feel of the breast. Approximately 75 percent of women in their forties have dense breasts, and this percentage typically decreases with age; 54 percent of women in their fifties and 42 percent of women in their sixties having dense breasts. Approximately 40 to 50 percent of women Hoag screens annually have extremely dense breast tissue, particularly younger women ages 40-49.

Regardless of dense breast tissue, mammograms and self breast awareness play a crucial role in early detection. Breast cancer is the second leading cause of cancer death among women, exceeded only by lung cancer. Statistics indicate one in eight women will develop breast cancer sometime in her lifetime.

The stage at which breast cancer is detected influences a woman's chance of survival. If found and treated early, while still localized in the breast, the ten-year survival rate for breast cancer is greater than 90 percent.

Hoag offers digital breast tomosynthesis to Orange County women due to a generous grant from Circle 1000, a group of women that have raised funds for Hoag Family Cancer Institute since 1987. In the near future, Hoag will be extending this technology to Irvine as well.

For more information: hoag.porternovelli.com/

Related Content

RSNA Study Shows Real-Time Indicator Improves Mammographic Compression
News | Mammography | December 12, 2018
Sigmascreening recently announced that more than 100,000 women have had mammography exams with the Sensitive Sigma...
Massachusetts Superior Court Grants Hologic Preliminary Injunction in Trade Secrets Lawsuits
News | Mammography | December 12, 2018
December 12, 2018 — A Massachusetts Superior Court granted a preliminary injunction in lawsuits by Hologic against Ch
Videos | Mammography | December 10, 2018
Stamatia Destounis, M.D., FACR, associate professor, University of Rochester School of Medicine, and attending radiol
FDA Clears iCAD's ProFound AI for Digital Breast Tomosynthesis
Technology | Mammography | December 07, 2018
iCAD Inc. announced clearance by the U.S. Food and Drug Administration (FDA) for their latest, deep-learning, cancer...
Fujifilm Collaborates With Lunit on AI Pilot Project
News | Artificial Intelligence | December 05, 2018
Fujifilm Medical Systems USA Inc. announced a joint collaboration with Korean-based medical artificial intelligence (AI...
ScreenPoint Medical and Volpara Partner to Bring AI to Breast Imaging Clinics
News | Computer-Aided Detection Software | December 04, 2018
ScreenPoint Medical has signed a memorandum of understanding (MOU) with Volpara Health Technologies. Volpara will...
ScreenPoint Medical Receives FDA Clearance for Transpara Mammography AI Solution
Technology | Computer-Aided Detection Software | November 28, 2018
November 28, 2018 — ScreenPoint Medical announced it has received 510(k) clearance from the U.S.
Women Benefit From Mammography Screening Beyond Age 75
News | Mammography | November 26, 2018
Women age 75 years and older should continue to get screening mammograms because of the comparatively high incidence of...
Novarad Debuts NovaMG-Pro Mammography Software at RSNA 2018
News | Mammography Reporting Software | November 25, 2018
Novarad Corp. announced new mammography software NovaMG-Pro, specifically for multimodality radiologists that read...
Volpara Solutions Showcases Latest VolparaEnterprise Software Tools at RSNA
News | Mammography | November 21, 2018
Volpara Solutions Inc. will showcase its latest artificial intelligence (AI) updates at the 104th Annual Radiological...